Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and ...

NORTHAMPTON, MA / ACCESS Newswire / June 23, 2025 / After captivating students across North America and Europe with access to hands-on science, the Curiosity Cube from the Life Science business of Mer ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance ...

China Pingjiang Pumped Storage Power Station’s first inclined diversion shaft was fully completed, marking a significant ...

Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the ...

Simtra BioPharma & MilliporeSigma enter strategic alliance for ADC drug substance and drug product manufacturing services: Parsippany, New Jersey Thursday, June 12, 2025, 15:00 Hr ...

DB InfraGO AG, the part of Deutsche Bahn responsible for infrastructure construction, has commissioned Implenia to build a ...

The platform ‘Fertility Unfiltered’ encourages open conversations around fertility, highlighting real stories and practical solutions to support women’s reproductive health ...

The need-to-know this morning. The FDA issued a “refuse-to-file” letter to ImmunityBio, turning back the company’s application to expand the approval of Anktiva, a drug used to treat ...

Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to all product orders shipped to the U.S.